Medical 21

Medical 21 is a private medical technology company focused on coronary artery bypass grafting (CABG) surgery. The company is developing MAVERICS, a small-diameter regenerative synthetic graft intended to replace harvested patient vessels during bypass procedures. Its lead product combines an absorbable polymer scaffold with a nitinol support structure designed to promote tissue integration while maintaining mechanical performance. Medical 21 is pursuing first-in-human clinical evaluation in Spain and positions its technology as a less invasive, more standardized alternative to vessel harvesting in cardiac bypass surgery. The company was founded by medtech entrepreneur Manny Villafaña and is headquartered in Minneapolis, Minnesota.